Impact of perinatal management on neurodevelopmental outcomes in congenital heart disease

Neeta Sethi1, Jessica L Carpenter2, Mary T Donofrio3

  • 1Duke Children's Pediatric and Congenital Heart Center, Duke University Medical Center, Durham, NC, USA.

Insights

Prenatal diagnosis of congenital heart disease (CHD) may improve perinatal care and preoperative status, potentially reducing brain injury and enhancing neurodevelopmental outcomes in neonates. This focus is crucial for CHD survivors.

Area of Science:

  • Pediatric Cardiology
  • Neonatal Neurology
  • Developmental Neuroscience

Background:

  • Neonatal surgical correction of congenital heart disease (CHD) has seen reduced mortality due to improved cardiopulmonary bypass and perioperative care.
  • Focus is shifting towards improving neurodevelopmental outcomes in CHD survivors.
  • Cerebral abnormalities in CHD patients often predate surgical repair, indicating prenatal factors are critical.

Purpose of the Study:

  • To review the impact of prenatal diagnosis of CHD on perinatal care.
  • To examine how prenatal diagnosis influences the preoperative clinical status of neonates.
  • To explore the potential of prenatal diagnosis in mitigating cerebral injury and improving long-term neurodevelopmental outcomes.

Main Methods:

  • Literature review on the effects of prenatal diagnosis of CHD.
  • Analysis of the relationship between prenatal diagnosis, perinatal care, and preoperative status.
  • Assessment of the influence on cerebral injury and neurodevelopmental outcomes.

Main Results:

  • Prenatal diagnosis of CHD can optimize perinatal care and preoperative clinical status.
  • Early identification may mitigate the severity of cerebral abnormalities.
  • Optimized perinatal management is linked to better long-term neurodevelopmental trajectories in infants with CHD.

Conclusions:

  • Prenatal diagnosis of CHD is a critical factor in optimizing perinatal care and preoperative status.
  • This approach holds significant potential for reducing brain injury and improving neurodevelopmental outcomes in neonates with CHD.
  • Further research into prenatal interventions is warranted to enhance long-term brain health in CHD survivors.

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
43
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
31
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
45
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
75
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
59
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
51